SCHEMBL2610405

SCHEMBL2610405

CCCc1nc(C)ncc1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 3/20 0.42
PDK4 Q16654 2/20 0.42
HSP90AA1 P07900 1/20 0.37
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 3/20 0.32
HPGD P15428 2/20 0.32
GFER P55789 1/20 0.32
HSD11B1 P28845 1/20 0.32
PDE10A Q9Y233 1/20 0.31
LMNA P02545 1/20 0.31
NPC1 O15118 2/20 0.31
MAPK1 P28482 2/20 0.31
RAB9A P51151 2/20 0.31
TKT P29401 1/20 0.31
DHFR P00374 1/20 0.31
HTT P42858 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
CNR1 P21554 1/20 0.31
CNR2 P34972 1/20 0.31
NFKB1 P19838 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2116606 0.85 KDM4E (0.38) PDK2PDK4KDM4EALDH1A1HPGD
SCHEMBL2116545 0.81 LMNA (0.40) PDK2PDK4KDM4EALDH1A1HPGD
SCHEMBL12539083 0.79 PDK2 (0.43) PDK2PDK4HSP90AA1KDM4EALDH1A1
SCHEMBL19573861 0.76 PDK2 (0.41) PDK2PDK4HSP90AA1LMNANPC1
SCHEMBL2115971 0.74 LMNA (0.49) KDM4EALDH1A1PDE10ALMNANPC1
SCHEMBL19574020 0.72 PDK2 (0.38) PDK2PDK4HSP90AA1KDM4EALDH1A1
SCHEMBL3944911 0.69 KDM4E (0.64) KDM4EALDH1A1HPGDGFERPDE10A
SCHEMBL2118864 0.69
SCHEMBL3396456 0.69
SCHEMBL5228304 0.68 HSP90AA1 (0.37) PDK2PDK4HSP90AA1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8268848-B2 Cyclopropane compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2012-09-18 US disclosed
US-20120095031-A1 CYCLOPROPANE COMPOUND EISAI R&D MANAGEMENT CO., LTD. (JP) 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095031-A1 CYCLOPROPANE COMPOUND HCRTR1, HCRTR2, CNR1 PDK2 4170/4885PDK4 3843/4885HSP90AA1 3281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.